Credit:Social Media
Credit:Social Media
Proven Protection The HPV vaccine has demonstrated over 90% effectiveness against cervical cancer
Credit:Social Media
Long-lasting Defence More than 15 years of research validates the vaccine's enduring protection
Credit:Social Media
Rigorous Testing Each vaccine underwent stringent safety tests before FDA approval
Credit:Social Media
UK Study Insights A 2021 UK study showcases a nearly 90% reduction in cervical cancer rates for vaccinated women
Credit:Social Media
Broader Cancer Defence Implications extend beyond cervical cancer, covering other 'high-risk' HPV-linked cancers
Credit:Social Media
Global Reassurance Accumulated research worldwide strengthens the safety and effectiveness claims